CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials
In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC
Cooperative Groups Not Included Among Grants to Be Funded At Recommended Levels
“Withheld” News Release On QRA Policies Released
CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch
DRCCA Board Oks Noncompetitive Contract Concepts
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Protecting the cure: Why the future of radiation oncology must be precision-guided
- Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research - NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Wafik El-Deiry steps down as director of Brown’s Legorreta Cancer Center









